Capecitabine induced hypertriglyceridaemia: An underreported and potentially severe side effect

Abstract

A 57 year-old-woman, with no previous history of dyslipedemia, developed severe hypertriglyceridemia while being treated with capecitabine for metastatic breast cancer. Capecitabine was not discontinued and serum triglyceride levels were normalized after 4 weeks of treatment with fenofibrate. Capecitabine induced hypertriglyceridemia, as a rare drugrelated side effect, seems to be often overlooked by clinicians.